Tempest Therapeutics Stock Forecast

TPST's stock price has decreased by -78.22% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Tempest Therapeutics stock has a target of 11, which predicts an increase of 550.89% from the current stock price of 1.69.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$11	$11	$11	$11
Change	+550.89%	+550.89%	+550.89%	+550.89%

* Price targets were last updated on Jan 22, 2026.

Analyst Ratings

According to 1 stock analyst, the rating for Tempest Therapeutics is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	0	0	1	1	1	1
Buy	1	1	0	0	0	0
Hold	2	2	1	1	1	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	2	2	2	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Hold → Strong Buy Upgrades $11	Hold → Strong Buy	Upgrades	$11	+550.89%	Jan 22, 2026
George Farmer Scotiabank	Scotiabank	Buy → Hold Downgrades $91 → $9	Buy → Hold	Downgrades	$91 → $9	+432.54%	Apr 10, 2025
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy → Hold Downgrades $16	Strong Buy → Hold	Downgrades	$16	+846.75%	Apr 10, 2025
George Farmer Scotiabank	Scotiabank	Buy Maintains $169 → $91	Buy	Maintains	$169 → $91	+5,284.62%	Mar 28, 2025
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $611 → $208	Strong Buy	Maintains	$611 → $208	+12,207.69%	Mar 28, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-1.37

from -6.33

EPS Next Year

-1.23

from -1.37

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	-	-	-	-	-
Revenue Growth	-	-	-	-	-	-	-
EPS	-97.07	-40.20	-24.87	-19.50	-6.33	-1.37	-1.23
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-1.41	-1.27
Avg	-1.37	-1.23
Low	-1.31	-1.19

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.